Best HealthTech Companies in Central District, Israel
The 112 best HealthTech companies in Central District, Israel in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Tyto Care.
Our analysis of 864 HealthTech companies
$73.2b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best HealthTech companies in Central District
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Tyto Care Online platform that records, stores, and sends data to enable medical consultations | $205M | 34 mo ago | 189 | 2011 | Ofer Tzadik Co-Founder & COO | Cart FunctionalityWordPressApple iCloud Mail+28 | 86 patents Telehealth diagnostic imaging and AI analysis for throat, vitals, and remote examinations | 2 launchs |
| 2 | Medial EarlySign AI platform that enables personal and outcome-based interpretation of medical records | $50M | 99 mo ago | 22 | 2013 | — | — | 3 patents Interpretability add‑ons for machine‑learning models in medical data analysis | — |
| 3 | G Medical Innovations Provider of a suite of devices for vital signs monitoring | $41M | 31 mo ago | 74 | 2014 | — | — | 164 patents Wearable thoracic impedance monitoring systems for fluid and respiratory diagnostics | — |
| 4 | OrSense Provider of non-invasive sensing technology for body vitals measurement | $33M | 181 mo ago | 24 | 1996 | Yoav Reisman CEO | WordPressMySQLPHP+14 | 60 patents Non‑invasive optical spectroscopy for measuring blood analytes and physiological parameters. | — |
| 5 | GluSense Implantable Glucose level sensor for Type 1 Diabetes patients | $27M | 112 mo ago | 6 | 2007 | — | — | 36 patents FRET-based continuous glucose biosensors for implantable, real-time analyte monitoring | — |
| 6 | CLEW Medical Provider of an AI-powered virtual ICU platform | $20M | 77 mo ago | 31 | 2014 | Avigdor Faians Co-Founder | WordPress Block EditorWordPressMySQL+25 | — | — |
| 7 | NovaSight Provider of eye-tracking-based solutions for vision assessment and treatment | $20M | 51 mo ago | 22 | 2016 | Michael Belkin Co-Founder | WordPressMySQLPHP+31 | 53 patents Vision therapy and diagnostic devices for refractive errors, amblyopia, and ocular motility | — |
| 8 | Panaxia Provider of medical cannabis products | $17M | 74 mo ago | 167 | 2009 | Dadi Segal Founder & CEO | WordPressMySQLPHP+22 | 2 patents Pharmaceutical compositions of benzyl‑alcohol mixtures for premature ejaculation treatment | — |
| 9 | KeePAP Provider of wearable device to monitor sleep apnea | $15M | 68 mo ago | — | 2012 | Alex Rapoport Founder & CEO | — | — | — |
| 10 | UltraSight AI-based platform providing ultrasound diagnosis for cardiac disorders | $14M | 36 mo ago | 29 | 2018 | Itay Kezurer Co-Founder | WordPress Site EditorWordPressApple iCloud Mail+22 | 24 patents AI‑enhanced ultrasound imaging for cardiac assist devices and probe positioning | 1 partnership · 1 award |
| 11 | Kyma Remote patient monitoring solutions for chronic cardiac patients | $10M | 152 mo ago | 11 | 2008 | Uriel Weinstein Co-founder | — | — | — |
| 12 | TechsoMed Developer of ultrasound-based monitoring systems for thermal ablation procedures | $10M | 63 mo ago | 27 | 2012 | — | — | — | 1 launch |
| 13 | DreaMed AI-based clinical decision support system for diabetes management | $8M | 22 mo ago | 27 | 2014 | Eran Atlas Co Founder & CEO | WordPressMySQLPHP+15 | — | — |
| 14 | HeraMED Developer of remote maternity monitoring platform and related smart devices | $7M | 30 mo ago | 21 | 2011 | — | WixSentryBootstrap+13 | — | 2 launchs · 1 award |
| 15 | Bio-T Medical Provider of cloud-based software for care planning and management | $6M | 59 mo ago | 37 | 2016 | Boaz Vaizler Co-Founder and COO/ Board Member | — | 91 patents Design and manufacturing of prosthetic heart valve frames and mitral valve implants | — |
| 16 | OWC Pharmaceutical Research Developer of cannabis-based therapeutics for multiple ailments | $5M | 97 mo ago | — | 2008 | Zvi Riterband CEO | — | — | — |
| 17 | AccuLine Developer of diagnostic device for the early detection of coronary artery disease | $4M | 23 mo ago | 6 | 2022 | Benny Shani CTO & Co-Founder | — | 3 patents Real-time multi-modal biosignal acquisition and processing for health monitoring | — |
| 18 | LAVAA Developer of an awareness system to promote proactive preventive care | $4M | 54 mo ago | 19 | 2021 | Izhak Lax Co-Founder and President | — | — | — |
| 19 | BioGaming 3D Virtual Reality games for Physiotherapy rehabilitation. | $4M | 140 mo ago | 18 | 2011 | Dudi Klein Founder & CEO | — | 20 patents Interactive motion‑tracked video‑game platforms for personalized physiotherapy and rehabilitation. | — |
| 20 | Oxitone Wrist-based Pulse Oximetry health monitor | $3M | 133 mo ago | 11 | 2010 | Leon Eisen Founder & Executive Chairman | WordPressMySQLPHP+23 | — | — |
| 21 | Algocell Provider of AI-powered bioprocess optimization solutions 27Talent top 38%AI top 45%Tech top 49%Funding bottom 42% All 6 signals ▾Talenttop 38% AItop 45% Techtop 49% Fundingbottom 42% Globalbottom 32% Marketbottom 25% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated AI: Product described with: ai-powered rank vs industry peers · Fliar Intelligence Index 27/100 | $3M | 11 mo ago | — | 2023 | Omri Schanin Co-Founder & CEO | WordPressMySQLPHP+21 | — | — |
| 22 | IMMA Health Provider of ovulation stimulation monitoring system 29Talent top 38%Funding bottom 43%Global bottom 36% All 3 signals ▾Talenttop 38% Fundingbottom 43% Globalbottom 36% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Funding: Raised $2.5M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 29/100 | $2M | 9 mo ago | — | 2020 | Beatrice Chemla Co Founder And Ceo | — | — | — |
| 23 | Formulex Developer of cannabinoid drug products | $1M | 208 mo ago | — | 2001 | Galia Krayz CEO | — | — | — |
| 24 | Biobeat Body vitals monitoring solution 48Tech top 34%Growth top 35%Product top 40%Funding top 46% All 7 signals ▾Techtop 34% Growthtop 35% Producttop 40% Fundingtop 46% Moattop 48% Globalbottom 38% Marketbottom 37% Tech: 38 technologies across 5/8 capability areas · Cloud: Amazon Web Services, Cloudflare Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 48/100 | $1M | 5 mo ago | 29 | 2014 | — | WordPressMySQLPHP+24 | — | 1 expansion |
| 25 | Elfi-Tech Developing technology for non-invasive physiological monitoring and diagnostics | $113K | 86 mo ago | 14 | 2006 | Ilya Fine Founder & CEO | — | 42 patents Non‑invasive optical blood‑pressure and hemodynamic monitoring using dynamic light scattering | — |
Top 12 HealthTech companies in Central District
#1
Series B · Petah Tikva, Central District · founded 2014 · 29 employees$1Mraised▾
Biobeat offers a non-invasive body vitals monitoring wearable solution. It uses reflective Pulse Oximetry technology with their algorithm to allow for constant measurements of related body vitals. Sensor delivers a range of body vitals measurement including consciousness, saturation, pulse, temperature and perspiration. The devices are connected to a mobile app or a central monitoring system where the user's data is stored. Data is then compared against a person's normal levels to identify life-threatening situations. It also allows data sharing with doctors and caregivers. They have released their products for athletes and Hospitals. Founded by Arik Ben Ishai Director of startups in the Rocket and Space Department of the Ministry of Defense, Israel.
- Dec 2025Series B$50M
- Oct 2019Grant (prize money)$188.5K
- Jun 2016Angel$1M
#2
Seed · Ra'anana, Central District · founded 2020$2.5Mraised▾
Provider of ovulation stimulation monitoring system. The company has developed an ultrasound like device for women to diagnose and monitor follicle stimulation and fertility status.
- Sep 2025Seed$2.5M
- Sep 2025Grant (prize money)—
#3
Seed · Rehovot, Central District · founded 2023$2.8Mraised▾
Provider of AI-powered bioprocess optimization solutions. It uses hybrid models, digital twins, and advanced AI technologies to accelerate bioprocess development and scale-up. The platform allows users to upload data, calibrate models, and create digital twins for gaining insights into cell line metabolism, optimizing protocols, and ensuring seamless transitions from pilot to manufacturing. This approach reduces trial-and-error experimentation, improves cell productivity, and enables real-time optimization during production. Key technologies include engineering models, data intelligence, design of experiments, AI optimization algorithms, and hybrid biological models.
- Jul 2025Seed$2.8M
- Jul 2025Grant (prize money)—
#4
Series D · Netanya, Central District · founded 2011 · 189 employees$205Mraised▾
Tyto care is a mobile and web-based health platform and device, allowing anyone to perform a self-physical examination, remote diagnosis, and consultation with a physician. Tyto Care's solution combines a handheld device and online communication platform designed to allow seamless interaction between patients and clinicians over the web. The device can be swiped across the forehead to receive temperature readings, used to record heart rate and rhythm and also lung sounds if a stethoscope attachment is used, used to capture digital images of the ear canal, throat or skin to enable diagnosing infections.
- Aug 2023Series D$49M
- Mar 2021Series D$50M
- Apr 2020Series D$50M
- Jan 2019Series C$9M
#5
Series A · Petah Tikva, Central District · founded 2014 · 27 employees$8.3Mraised▾
AI-based clinical decision support system for diabetes management. The company's first product launch is Endo.digital, a cloud-based SAAS platform that gives care provider organizations an end-to-end diabetes care pathway that can be deployed across all care settings where patients with diabetes are treated, both remotely and in person.
- Aug 2024Series A$3M
- Sep 2017Series A—
- Jul 2016Series A$3.3M
- Feb 2016Grant (prize money)$3.4M
#6
Public · Rehovot, Central District · founded 2014 · 74 employees$41.3Mraised▾
Provider of a suite of devices for vital signs monitoring. The company offers a range of consumer and Hospital grade medical devices for early detection and diagnosis of patients as well as remote monitoring. The company offers prizma G2, a smartphone case transforming any smartphone into a medical monitoring and diagnostic smartphone that captures a wide range of vital signs. The mobile application helps to collects and analyses medical data and determines correlations between tests. The company also offers – G MEDICAL PATCH (GMP), a bio-sensor monitoring system, which can be used in hospital care and post-discharge programs for continuous, real-time monitoring.
- Oct 2023Post IPO$500K
- Apr 2022Post IPO—
- Jan 2022Post IPO—
- May 2020Series B$6M
#7
Seed · Central District · founded 2022 · 6 employees$4.2Mraised▾
Developer of diagnostic device for the early detection of coronary artery disease. The company is developing CORA a smart device with machine-learning algorithms for the early detection of coronary artery disease.
- Jul 2024Seed$4.2M
- Jul 2024Grant (prize money)—
#8
Public · Netanya, Central District · founded 2011 · 21 employees$6.7Mraised▾
Developer of remote maternity monitoring platform and related smart devices. The platform offers customizable care plans, telehealth video and chat, and smart messaging. It provides remote patient monitoring, educational content, and prenatal and postpartum care. The platform aims to streamline care delivery and facilitate real-time patient health monitoring. It captures vitals, prioritizes out-of-range measurements, and manages patient adherence through a care management dashboard.
- Dec 2023Post IPO$1.2M
- Aug 2022Post IPO$4M
- Dec 2019Post IPO$1.4M
#9
Series B · Rehovot, Central District · founded 2018 · 29 employees$14.1Mraised▾
AI-based platform providing ultrasound diagnosis for cardiac disorders. The platform provides solutions for clinical decision support through cardiac imaging and sonography. The software can be paired with ultrasound devices for sonography analysis and diagnosis.
- Jun 2023Series B$1.1M
- May 2021Series B$13M
#10
Series B · Lod, Central District · founded 2016 · 22 employees$20Mraised▾
Provider of eye-tracking-based solutions for vision assessment and treatment. It offers medical devices to prevent vision impairments among pediatric patients using eye-tracking-based technology in novel diagnostic, therapeutic, and preventive solutions. Its products include CureSight an amblyopia treatment system, designed to replace traditional eye patching, TrackSight a software-based vision health monitoring and myopia prevention system, and Eye swift an eye-tracking-based vision diagnostics system.
- Mar 2022Series B—
- Jul 2020Series A$8M
#11
Series B · Kfar Saba, Central District · founded 2013 · 22 employees$50Mraised▾
Medial EarlySign develops a machine learning based decision support tool. This tool enables personal and outcome-based interpretation of medical data, yielding individualized predictions and treatment options for each patient, as well as early prediction of life-threatening conditions. Their first commercial use case focuses on the early prediction of colorectal cancer (CRC). The solution can indicate a high probability of CRC. MeScore performs the analysis instantaneously, using only standard medical data, and automatically alerts upon high-risk results.
- Mar 2018Series B$30M
#12
Series B · Netanya, Central District · founded 2014 · 31 employees$20.5Mraised▾
Provider of an AI-powered virtual ICU platform. The company provides a predictive analytics solution for healthcare providers to improve the intensive care unit (ICU) clinical outcome while reducing hospital costs. The analytics engine detects health deterioration in real time and delivers predictive warnings during all phases of a patient's ICU stay.
- Jan 2020Series B$10M
- Dec 2017Series A$10.5M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of HealthTech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.